Displaying 1–25 of 109 results for Karen Langhauser, Chief Content Director

Sort By Relevance Sort By Date
1 2 3 4 5

To biopharma: Which elephant?

(Article)

Biopharma is taking small steps towards solving one of many jumbo challenges

Infographic — Data management study finds pharma is not capitalizing on ...

(Article)

Infographic — Data management study finds pharma is not capitalizing on technology

The elephant in the biopharma classroom

(Article)

Biopharma needs to address its workforce training methods

Pharma: Reluctant revolutionaries

(Article)

Pharma needs to rally behind digital if it wants to see real change

Recharging pharma's digital revolution

(Article)

Is the luster of digital transformation in pharma fading?

Pharma's high hopes

(Article)

Pharma's gene therapy dreams need to be tethered with a plan

Pharma innovation: Depends how you slice it

(Article)

The definition of pharma innovation isn’t always clear cut

2019 Pharma Innovation Awards

(Article)

Pharma Manufacturing's annual Pharma Innovation Award winners offer slices of innovation

Joint ventures in pharma (and nature)

(Article)

Shared pursuits might lead to bigger rewards

Solid Dose: Under-hyped but not under-represented

(Article)

The buzz may be around biologics, but the oral solid dose sector is still going strong

INTERPHEX 2019: Still hip at forty

(Article)

INTERPHEX 2019 conference recap

Revalidating grandpa

(Article)

For pharma, it pays to update facilities and mindsets

Pharma shoots for the moon

(Article)

Reaching new frontiers will require both strategic and financial planning

Race to the biosimilar space

(Article)

Pharma navigates unfriendly terrain to reach the next frontier in affordable drugs

New look, same great taste

(Article)

Pharma finds balance

(Article)

Despite negative public opinions and heavy demands, survey respondents indicate rising satisfaction and pride in their work

Pharma's Rep: Redeeming the Seedy & Greedy

(Article)

Can the pharma industry restore luster to its dimming reputation?

Generics Surge Forward

(Article)

AAM Access! 2019 makes it clear that generics have earned their seat at the table

Changing Cupid's Contract

(Article)

Pharma CMOs are sharpening their arrows and getting noticed

Build Biologics Not Barriers

(Article)

iBio’s unique partnership with Beijing’s CC-Pharming will bring economical, plant-derived rituximab to China

Sustainable Drugs From the Start

(Article)

China-based Porton Pharma’s partnership with Codexis will bring new and improved manufacturing routes for APIs

Sound Advice

(Article)

This year, pharma regulators faced their own music

Pharmaceutical Manufacturing's Year in Review

(Article)

As Pharmaceutical Manufacturing sends its final issue of 2018 to the printer, we’d like to take this opportunity to reflect on some of our favorite highlights:

An Injection a Day

(Article)

Premature promises about cell therapies create expectations ripe for disappointment

The dangers of unproven cell therapies

(Article)

Can unproven therapies spoil the sector’s sweet success?

Sort By Relevance Sort By Date
1 2 3 4 5